Literature DB >> 24725354

Hemodialysis for infants, children, and adolescents.

Amrit Kaur1, Andrew Davenport.   

Abstract

Children with chronic kidney disease stage 5 requiring dialysis can be treated by peritoneal or hemodialysis. In the United Kingdom nearly twice as many children receive peritoneal dialysis compared with hemodialysis. Technical aspects of pediatric hemodialysis are challenging and include the relative size of extracorporeal circuit and child's blood volume, assessment of adequacy,technical and complications of vascular access. Alternatives to standard hospital-based hemodialysis are also increasingly available. Optimizing nutritional status with the support of specialist pediatric dietitians is key to the management of children receiving hemodialysis. The effects of chronic illness on growth and school achievement, as well as the psychological, emotional, and social development of the child should not be underestimated. This review focuses on the above elements and highlights common pediatric practice in the United Kingdom.
© 2014 International Society for Hemodialysis.

Entities:  

Keywords:  Children; adolescents; hemodialysis; infants

Mesh:

Year:  2014        PMID: 24725354     DOI: 10.1111/hdi.12163

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  8 in total

1.  Children tolerate intradialytic oral nutrition.

Authors:  Andrew M South; Bonnie Fainman; Scott M Sutherland; Cynthia J Wong
Journal:  J Ren Care       Date:  2017-12-12

2.  Plasma pseudouridine levels reflect body size in children on hemodialysis.

Authors:  Frank J O'Brien; Tammy L Sirich; Abigail Taussig; Enrica Fung; Lakshmi L Ganesan; Natalie S Plummer; Paul Brakeman; Scott M Sutherland; Timothy W Meyer
Journal:  Pediatr Nephrol       Date:  2019-11-14       Impact factor: 3.714

3.  Dalteparin anticoagulation in paediatric home haemodialysis.

Authors:  Miranda Lutkin; Lynsey Stronach; Pallavi Yadav; Daljit K Hothi
Journal:  Pediatr Nephrol       Date:  2018-09-01       Impact factor: 3.714

4.  Use of complementary and alternative medicines in haemodialysis patients: a cross-sectional study from Palestine.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Ghada H Tabeeb; Nora A Ayaseh; Mayas N Sawafta; Razan L Khdeir; Diana O Mezyed; Dala N Daraghmeh; Rahmat Awang
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

Review 5.  Optimizing Enteral Nutrition for Growth in Pediatric Chronic Kidney Disease (CKD).

Authors:  Christina L Nelms
Journal:  Front Pediatr       Date:  2018-08-02       Impact factor: 3.418

6.  Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Kidney Res Clin Pract       Date:  2021-12-10

7.  Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Kidney Res Clin Pract       Date:  2021-12-10

Review 8.  Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Korean J Intern Med       Date:  2022-06-03       Impact factor: 3.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.